Uncategorized
SignPost Selected for NewChip Accelerator
SignPost was accepted into Newchip”‘s renowned global accelerator program. Designed to provide all the skills and tools seed-stage founders need to rapidly fund, build and scale their companies, past accelerator cohorts averaged more than 17.5 times the average funding amount. “Newchip evaluates a vast and diverse number of seed-stage companies from around the globe, selecting…
Read MoreBreast Cancer over takes lung as most common cancer
GENEVA (Reuters) –Breast cancer has overtaken lung cancer as the most common form of the disease, accounting for nearly 12% of new cases each year worldwide, the World Health Organization said on Tuesday. “For the first time, breast cancer now constitutes the most commonly occurring cancer globally,” Andre Ilbawi, a cancer specialist at the WHO,…
Read MoreSignPost Selected to Present at the 2021 BioConnect Conference Hosted by H.C. Wainwright
January 7, 2021 – Ontario, Canada – Signpost Cancer Analytics Inc. Inc. (“SignPost” or “company”), a company developing an advanced molecular diagnostic test to identify invasive breast cancer, announced today that Mr. Peter Blaney, Chief Executive Officer, will present at the 2021 BioConnect Conference hosted by H.C. Wainwright. Registered attendees can access the recorded presentation…
Read MoreSeason’s Greetings from SignPost
Dear Friends, As the holiday season begins, we hope that this update finds you and your family safe and healthy. With 2020 coming to a close, we wanted to take the time to review several positive milestones, advancements, and achievements as well as highlight new opportunities that are on the horizon for 2021. The summary…
Read MoreWhy Early Detection is Critical to Extending Life for Cancer Patients.
Take a listen to Peter Attias interview with Dr. Raza . Peter Attia is a Canadian-American physician of Egyptian descent known for his medical practice that focuses on the science of longevity. He is also the first person to make the round-trip swim from Maui and Lanai. Dr. Azra Raza is a physician, scientist, author,…
Read MoreThe Conspiracy of Hope
Renée Pellerin is a former CBC health journalist and the author ofConspiracy of Hope, The Truth About Breast Cancer Screening, published by Goose Lane Editions. Below is an except from her article in the Globe and Mail responding to the new guidelines publishedby the CanadianTask Force on Preventative Health Care forbreast cancer screening. “Every woman…
Read MoreThe Difficulties of Diagnosing Inflammatory Breast Cancer
Dr Kathy D. Miller of Indianan University explains in this video the difficulty in diagnosing inflammatory breast cancer. Dr. Miller describes a common scenario among doctors diagnosing inflammatory breast cancer. Currently there is no clear answer, as the quote below describes a patients symptoms and the varying opinions of the team of doctors. “The patient…
Read MoreThe Value of Molecular Diagnostics
To better understand the technology that BreastDefense is using, a report byAdvaMedDxgives is a very good overview of the molecular diagnostic field. “The introduction and expanding use of molecular diagnostic tests to detect cancer and manage cancer care mark a major milestone and herald future progress in the fight against this disease – begins thereportbyAdvaMedDxa…
Read MoreBreast Biopsies – are not always accurate
The video The Pathology of Errors is about the consequences of a inaccurateimage reading. Since treatment is based on the diagnosis of the pathologists report, it is critical that the diagnosis is correct. It is now recommended that women seek second opinions when given a diagnosis of breast cancer. This video is a good overview…
Read More40 over 40
40% of Women Over 40 Have Dense Breasts. Why does this matter? Fact the denser the breast the higher the risk of getting breast cancer. Fact having dense breasts is a greater risk factor than having a family history of breast cancer. Fact mammograms miss about 50% of breast cancer in the densest breasts. The…
Read More